Genetic remodeling of protein glycosylation in vivo induces autoimmune disease.

Autoimmune diseases are among the most prevalent of afflictions, yet the genetic factors responsible are largely undefined. Protein glycosylation in the Golgi apparatus produces structural variation at the cell surface and contributes to immune self-recognition. Altered protein glycosylation and antibodies that recognize endogenous glycans have been associated with various autoimmune syndromes, with the possibility that such abnormalities may reflect genetic defects in glycan formation. We show that mutation of a single gene, encoding alpha-mannosidase II, which regulates the hybrid to complex branching pattern of extracellular asparagine (N)-linked oligosaccharide chains (N-glycans), results in a systemic autoimmune disease similar to human systemic lupus erythematosus. alpha-Mannosidase II-deficient autoimmune disease is due to an incomplete overlap of two conjoined pathways in complex-type N-glycan production. Lymphocyte development, abundance, and activation parameters are normal; however, serum immunoglobulins are increased and kidney function progressively falters as a disorder consistent with lupus nephritis develops. Autoantibody reactivity and circulating immune complexes are induced, and anti-nuclear antibodies exhibit reactivity toward histone, Sm antigen, and DNA. These findings reveal a genetic cause of autoimmune disease provoked by a defect in the pathway of protein N-glycosylation.

[1]  J. Marth,et al.  Immune regulation by the ST6Gal sialyltransferase. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[2]  S. Tsuboi,et al.  Core 2 oligosaccharide biosynthesis distinguishes between selectin ligands essential for leukocyte homing and inflammation. , 1998, Immunity.

[3]  B. Kotzin Systemic Lupus Erythematosus , 1996, Cell.

[4]  R. Cummings,et al.  Expression of Lex antigen in Schistosoma japonicum and S.haematobium and immune responses to Lex in infected animals: lack of Lex expression in other trematodes and nematodes. , 1998, Glycobiology.

[5]  J. Marth,et al.  Alpha-Mannosidase-II Deficiency Results in Dyserythropoiesis and Unveils an Alternate Pathway in Oligosaccharide Biosynthesis , 1997, Cell.

[6]  Y. Hiki,et al.  Underglycosylation of IgA1 hinge plays a certain role for its glomerular deposition in IgA nephropathy. , 1999, Journal of the American Society of Nephrology : JASN.

[7]  H. Schachter,et al.  The 'yellow brick road' to branched complex N-glycans. , 1991, Glycobiology.

[8]  A. Herscovics,et al.  Glycosidases of the asparagine-linked oligosaccharide processing pathway. , 1994, Glycobiology.

[9]  T. Honjo,et al.  Development of lupus-like autoimmune diseases by disruption of the PD-1 gene encoding an ITIM motif-carrying immunoreceptor. , 1999, Immunity.

[10]  K. Okada,et al.  Therapeutic efficacy of non-peptide ADH antagonist OPC-31260 in SIADH rats. , 1993, Kidney international.

[11]  P. Delves The role of glycosylation in autoimmune disease. , 1998, Autoimmunity.

[12]  V. Kouskoff,et al.  Organ-Specific Disease Provoked by Systemic Autoimmunity , 1996, Cell.

[13]  H. Freeze,et al.  Carbohydrate-deficient glycoprotein syndrome type Ib. Phosphomannose isomerase deficiency and mannose therapy. , 1998, The Journal of clinical investigation.

[14]  J. Marth,et al.  Isolation, characterization and inactivation of the mouse Mgat3 gene: the bisecting N-acetylglucosamine in asparagine-linked oligosaccharides appears dispensable for viability and reproduction. , 1997, Glycobiology.

[15]  S. Kornfeld,et al.  Assembly of asparagine-linked oligosaccharides. , 1985, Annual review of biochemistry.

[16]  R. Dwek,et al.  Association of rheumatoid arthritis and primary osteoarthritis with changes in the glycosylation pattern of total serum IgG , 1985, Nature.

[17]  D. Salant,et al.  Altered glomerular permeability induced by F(ab')2 and Fab' antibodies to rat renal tubular epithelial antigen. , 1982, Kidney international.

[18]  J. Miyazaki,et al.  Expression and function of a nonglycosylated major histocompatibility class I antigen , 1986, The Journal of experimental medicine.

[19]  L. Steinman,et al.  Escape from “horror autotoxicus”: Pathogenesis and treatment of autoimmune disease , 1995, Cell.

[20]  E. Tan Autoantibodies in pathology and cell biology , 1991, Cell.

[21]  Carolyn R. Bertozzi,et al.  Essentials of Glycobiology , 1999 .

[22]  Mark Sutton-Smith,et al.  A rapid mass spectrometric strategy suitable for the investigation of glycan alterations in knockout mice , 2000 .

[23]  P. Gleeson Glycoconjugates in autoimmunity. , 1994, Biochimica et biophysica acta.

[24]  L. Kappos,et al.  Self glycolipids as T‐cell autoantigens , 1999, European journal of immunology.

[25]  N. Rose,et al.  Critical self-epitopes are key to the understanding of self-tolerance and autoimmunity. , 1999, Immunology today.

[26]  J. Cyster,et al.  Polygenic autoimmune traits: Lyn, CD22, and SHP-1 are limiting elements of a biochemical pathway regulating BCR signaling and selection. , 1998, Immunity.

[27]  J. Ravetch,et al.  Uncoupling of immune complex formation and kidney damage in autoimmune glomerulonephritis. , 1998, Science.

[28]  H. Freeze,et al.  Correction of leukocyte adhesion deficiency type II with oral fucose. , 1999, Blood.